Novartis Pharma emerged as one of the front runners of the swine flu vaccine race when the first experimental batch was released in early June. However, Novartis vaccines don’t represent even a quarter of the earnings so an achievement in the swine flu vaccine shouldn’t create a significant impact over Novartis share price.

The effects of Tamiflu and Relenza in young children under 12 have proven to be uneffective. All it seems to do is delaying the swine flu symptoms by 1 day, so the child can go to school and infect other children. The swine flu antiviral medication is only effective in 8% of the swine flu cases; if you want to cure a swine flu case of a child 12, you would have to supply the swine flu antiviral to up to 13 children.